Loading…

IBEX LtdIBEXCompetitor analysis, valuation and peers

United States · USD·Industrials›Miscellaneous Commercial Services
Momentum leader 98
Mkt cap
$744M
US dollars, full cap
Free float
80%
of shares outstanding
$/day
$8.13M
20-day average traded
Fwd P/E
13.5×
forward earnings
ROIC−WACC
+14.6 pp
WACC 8.5%
Hurdle
-7 pp
Req g minus delivered
Next earnings
91 days
17 Feb 2027
Close · USD$55.77
1D+0.5%
1W+0.8%
1M+21.2%
3M+54.4%
6M+78.7%
YTD+46.1%
1Y+58.6%
ATR %3.8%
Beta0.63
52w lowhigh3.7% off high

What IBEX does

Employees: 35,000

IBEX at a glance

Size IBEX (IBEX) is a United States Industrials company (Miscellaneous Commercial Services) with a market value of $744M, the 2419th largest of 3,085 United States companies the cockpit tracks. Shares closed at $55.77 on 18 Nov 2026.

Performance Over six months the shares gained 78.7%, against -11.9% for the median peer and -2.2% for the United States market (cap-weighted) — 2nd highest of 21 in its peer set.

Growth Revenue grew 15.2% over the last twelve months (peer median +7.5%); the operating margin is 9.1% (peer median 3.9%).

Valuation It trades at 13.5× forward earnings against a peer median of 24.1× (4th cheapest of 15).

Price implies For today's price to make sense, revenue must grow about 1% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -7 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 14.6 points above its cost of capital (8.5% WACC).

Short interest Short interest is 1.4% of the free float (30 Oct 2026).

Next results Next results expected around 17 Feb 2027 (exchange calendar; dates can move).

Relative performance

10015021 May 202621 Aug 202618 Nov 2026IBEX 174Peer median 87
Six months, rebased to 100: IBEX against the median of its 20 peers (local-currency closes).

IBEX financials

Reported figures in USD; fiscal year ends 2026-06-30. TTM = trailing twelve months.
TTMFY2026FY2025FY2024FY2023
Revenue$668M$644M$558M$509M$523M
Revenue growth—+15%+10%-3%—
Gross profit$180M$171M$155M$133M$130M
EBITDA$81.4M$76.9M$65.9M$60.7M$75.1M
Net income$49.1M$46.3M$36.9M$33.7M$31.6M
Free cash flow$32.3M$31.2M$27.3M$27.0M$22.9M
Capital expenditure$27.3M$27.8M$18.4M$8.86M$19.0M
Total debt$63.8M$62.4M$69.8M$67.0M$78.9M

Quarterly statements and history in the cockpit →

IBEX competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%300860001207688530CCL97576039553009490009K0603373CCP301230688150688787AUBBVMTRI002915IBEX6-month return →1-month return →
Up and to the right = strong over both horizons. IBEX is the large dot.

Fundamentals: revenue growth against valuation

-40%-20%0%+20%+40%0×200×400×600×300860001207CCL9757300688002649301230688150688787AUBIBEXRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. IBEX is the large dot.

Capital: growth delivered against growth the price implies

0%+200%+400%+600%0%200%400%600%30086000120797570009K0IBEXGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. IBEX is the large dot.

IBEX competitors and peer comparison

How IBEX compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

IBEX against its 20 peers (data as of 18 Nov 2026)
MeasureIBEXPeer medianRank in peer set
1-month return+21.2%-9.6%2nd highest of 21
6-month return+78.7%-11.9%2nd highest of 21
Distance from 52-week high-3.7%-38.9%2nd highest of 21
Revenue growth (TTM)+15.2%+7.5%7th highest of 21
Operating margin9.1%3.9%9th highest of 21
Forward P/E13.5×24.1×4th cheapest of 15
Growth the price implies (Req g, 7 yrs)1.0%4.1%3rd least demanding of 11
Growth delivered (Del g)+7.7%+8.2%6th highest of 11
Hurdle (Req g minus delivered)-6.7 pp-4.6 pp5th least demanding of 11
ROIC minus cost of capital+14.6 pp-3.4 pp2nd highest of 19
EV / EBITDA9.5×8.6×3rd most expensive of 6
Net debt / EBITDA0.3×-1.0×3rd most indebted of 7

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
IBEX IBEXUnited States$744M+79%+15%9%13.5×1.0%+7.7%
Funshine Culture 300860.SZChina$739M0%-49%-35%24.2×21.5%-24.6%
Shandong Link Science and Technology 001207.SZChina$733M-24%+7%13%11.6×-5.5%+18.9%
Omat Advanced Materials (Guangdong) 688530.SSChina$757M-19%+82%9%n/an/an/a
Cuscal CCL.AXAustralia$728M+17%+19%12%18.1×n/an/a
Funai Soken 9757.TJapan$724M+10%+5%25%16.2×-8.7%+5.9%
Dark Horse Technology 300688.SZChina$723M+12%-32%-33%576.0×n/an/a
Daqian Ecology & Environment 603955.SSChina$769M+21%+217%-53%n/an/an/a
Beyondsoft 002649.SZChina$769M-14%-6%2%24.1×7.0%+9.2%
Shenzhen L&A Design 300949.SZChina$715M+98%0%-28%n/an/an/a
Aimed Bio 0009K0.KSSouth Korea$778M-61%+228%34%n/a10.2%+652.2%
Anbang Save-Guard 603373.SSChina$779M+6%-1%14%38.9×5.6%+5.6%
Credit CCP.AXAustralia$704M+39%+7%26%9.4×1.9%+11.1%
PharmaResources (Shanghai) 301230.SZChina$695M-10%+9%0%76.5×39.0%+19.5%
Shaanxi Lighte Optoelectronics Material 688150.SSChina$692M-56%+14%39%36.4×n/an/a
Beijing Haitian Ruisheng Science Technology 688787.SSChina$801M-37%+34%4%126.5×n/an/a
Aubay AUB.PAFrance$690M-7%+27%9%12.9×2.6%+7.1%
BrightView BVUnited States$803M-29%+1%4%19.6×n/an/a
Mentari Therapeutics MTRIUnited States$807M-91%-83%-1,239%n/an/an/a
Zhejiang Zhongxin Fluoride Materials 002915.SZChina$683M-41%+8%2%59.0×n/an/a
Guizhou Zhenhua E-Chem 688707.SSChina$681M-44%+15%-17%n/a1.9%+6.6%

Questions

Which companies are IBEX's closest peers?
The cockpit's peer set: Funshine Culture (300860.SZ), Shandong Link Science and Technology (001207.SZ), Omat Advanced Materials (Guangdong) (688530.SS), Cuscal (CCL.AX), Funai Soken (9757.T), Dark Horse Technology (300688.SZ), Daqian Ecology & Environment (603955.SS), Beyondsoft (002649.SZ).
Is IBEX expensive compared with its peers?
On forward p/e it trades at 13.5× against a peer median of 24.1×, 4th cheapest of 15 in its peer set. For today's price to make sense, revenue must grow about 1% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -7 pp: the price already allows for a slowdown.
How has IBEX stock performed?
Over six months to 18 Nov 2026 the shares returned +78.7% against -11.9% for the median peer; over one year +58.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.